Beijing Health (Holdings) Limited (HKG:2389)
Hong Kong · Delayed Price · Currency is HKD 0.0920
-0.0030 (-3.16%)
Jul 22, 2025, 3:44 PM HKT
Beijing Health (Holdings) Revenue
In the year 2024, Beijing Health (Holdings) had annual revenue of 149.95M HKD with 6.84% growth. Beijing Health (Holdings) had revenue of 76.64M in the half year ending December 31, 2024, with 2.63% growth.
Revenue
149.95M
Revenue Growth
+6.84%
P/S Ratio
3.72
Revenue / Employee
837.68K
Employees
179
Market Cap
557.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 149.95M | 9.60M | 6.84% |
| Dec 31, 2023 | 140.35M | -26.14M | -15.70% |
| Dec 31, 2022 | 166.48M | -37.29M | -18.30% |
| Dec 31, 2021 | 203.78M | 53.89M | 35.95% |
| Dec 31, 2020 | 149.89M | -50.87M | -25.34% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |